Results 171 to 180 of about 469,352 (221)

Conjugate pneumococcal vaccines: an overview

Medical Journal of Australia, 2000
A seven-valent conjugate pneumococcal vaccine has been shown to have dramatic efficacy against invasive pneumococcal disease and lesser efficacy against otitis media and pneumonia. This vaccine was licensed for use in infants in the United States in February 2000 and is recommended there for routine use in infants and catch-up vaccination in high-risk ...
openaire   +2 more sources

Pneumococcal Conjugate Vaccines

1995
The development of multivalent pneumococcal vaccines for the prevention of both systemic and noninvasive pneumococcal diseases in infants, older adults, and immunecompromised individuals has gained increasing importance over the last decade. The rising cost of medical care has renewed interest in prevention instead of cure for a disease and in many ...
openaire   +2 more sources

The potential of pneumococcal conjugate vaccines for children

The Pediatric Infectious Disease Journal, 2002
In contrast to earlier pneumococcal vaccines, conjugate vaccines hold promise for reducing pneumococcal morbidity and mortality in infants and young children. The first commercially available conjugate vaccine formulation, which targets seven serotypes, was licensed in the US and other countries in 2000; this vaccine is now part of routine infant ...
Cynthia G, Whitney, Larry K, Pickering
openaire   +2 more sources

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

European Journal of Clinical Microbiology & Infectious Diseases, 2007
The French Pediatric Infectious Diseases Group set up an active surveillance network to analyze the clinical and biological features of pneumococcal meningitis and the impact of the seven-valent pneumococcal conjugate vaccine (PCV7). From 2001 to 2005, 234 pediatric wards working with 166 microbiology laboratories enrolled all children with ...
E, Bingen, C, Levy, E, Varon, F, de La Rocque, M, Boucherat, P, d'Athis, Y, Aujard, R, Cohen   +7 more
openaire   +2 more sources

Pneumococcal Conjugate Vaccines

Pediatric Annals, 1999
J, Eskola, M, Anttila
openaire   +4 more sources

The pneumococcal conjugate vaccine.

Minerva pediatrica, 2003
Streptococcus pneumoniae is the most frequent cause of otitis media, sinusitis, and pneumonia in children. It is also one of the most common causes of invasive bacterial infections in children including bacteremia and meningitis. One of the current issues regarding S. pneumoniae is the emergence of pneumococcal strains resistant to penicillin and other
R M, Jacobson, G A, Poland
openaire   +1 more source

Effectiveness of pneumococcal conjugate vaccine

The Lancet, 2006
Katherine L, O'Brien, Orin S, Levine
openaire   +2 more sources

Pneumococcal disease and conjugate vaccines

Enfermedades Infecciosas y Microbiología Clínica, 2018
Jordi, Càmara, Carmen, Ardanuy
openaire   +2 more sources

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Vaccine, 2021
Kathrin U Jansen, Íngrid Scully, Daniel Scott   +2 more
exaly  

Pneumococcal-vaccine-conjugate

Reactions Weekly, 2021
openaire   +1 more source